DermaGen Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
DermaGen General Information
Description
Developer of antimicrobial peptides directed against skin microbes. The company develops peptides which exert potent antimicrobial effects and are derived from endogenous human proteins, such as those of the complement system, as well as several other skin and blood-derived proteins.
Contact Information
Corporate Office
- Scheelevägen 22
- SE-223 63 Lund
- Sweden
Corporate Office
- Scheelevägen 22
- SE-223 63 Lund
- Sweden
DermaGen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 01-Dec-2010 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 02-Apr-2008 | Completed | Startup | |||
| 1. Corporate | Completed | Startup |
DermaGen Patents
DermaGen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2012033450-A1 | Novel antimicrobial peptides | Inactive | 07-Sep-2010 | ||
| ES-2476590-T3 | Enhanced antimicrobial peptides | Active | 16-May-2006 | ||
| WO-2007133153-A1 | Improved antimicrobial peptides | Inactive | 16-May-2006 | ||
| WO-2007133153-A8 | Improved antimicrobial peptides | Inactive | 16-May-2006 | ||
| CA-2637216-A1 | Novel antimicrobial peptides and use thereof | Inactive | 10-Feb-2006 | C07K14/4723 |
DermaGen Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Granitor | Venture Capital | Minority | ||
| KDventures | Venture Capital | Minority | ||
| LU Ventures (Lund) | Corporate Venture Capital | Minority | ||
| Östersjöstiftelsen | Limited Partner | Minority |
DermaGen Investments (1)
DermaGen’s most recent deal was a Early Stage VC with XImmune for . The deal was made on 01-Jan-2009.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| XImmune | 01-Jan-2009 | Early Stage VC | Drug Discovery |
DermaGen FAQs
-
When was DermaGen founded?
DermaGen was founded in 2004.
-
Where is DermaGen headquartered?
DermaGen is headquartered in Lund, Sweden.
-
What industry is DermaGen in?
DermaGen’s primary industry is Drug Discovery.
-
Is DermaGen a private or public company?
DermaGen is a Private company.
-
What is DermaGen’s current revenue?
The current revenue for DermaGen is .
-
How much funding has DermaGen raised over time?
DermaGen has raised $1.56M.
-
Who are DermaGen’s investors?
Granitor, KDventures, LU Ventures (Lund), and Östersjöstiftelsen have invested in DermaGen.
-
When was DermaGen acquired?
DermaGen was acquired on 01-Dec-2010.
-
Who acquired DermaGen?
DermaGen was acquired by Pharmasurgics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process